Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 11, 2019

Total Value ($000): $134,874 (100.0% shares, 0.0% debt)

Holdings (14)

REPL Replimune 37.8%

Value ($000) $51,035 Shares 5,103,455 Est. Cost $17.53 Unrealized -22.9%

— Translate Bio 13.6%

Value ($000) $18,282 Shares 2,437,603 Est. Cost $12.65 Unrealized —

— KezarLife Sciences 11.8%

Value ($000) $15,945 Shares 675,623 Est. Cost $17.30 Unrealized —

— Paratek Pharmaceuticals 9.9%

Value ($000) $13,340 Shares 2,600,410 Est. Cost $34.18 Unrealized —

— ObsEva 9.4%

Value ($000) $12,652 Shares 999,364 Est. Cost $9.76 Unrealized —

— FibroGen 4.5%

Value ($000) $6,046 Shares 130,646 Est. Cost $27.34 Unrealized —

— CymaBay Therapeutics 3.2%

Value ($000) $4,340 Shares 551,477 Est. Cost $4.71 Unrealized —

— Cidara Therapeutics 2.6%

Value ($000) $3,546 Shares 1,508,794 Est. Cost $6.73 Unrealized —

— BSSA Pharma 1.7%

Value ($000) $2,278 Shares 1,084,848 Est. Cost $3.00 Unrealized —

— Pieris Pharmaceuticals 1.5%

Value ($000) $2,070 Shares 778,230 Est. Cost $1.83 Unrealized —

— Dicerna Pharmaceuticals 1.3%

Value ($000) $1,787 Shares 167,157 Est. Cost $16.47 Unrealized —

— Jounce Therapeutics 1.3%

Value ($000) $1,786 Shares 529,965 Est. Cost $21.99 Unrealized —

SNNAQ Sienna Biopharmaceuticals 1.3%

Value ($000) $1,760 Shares 758,610 Est. Cost $21.95 Unrealized -59.8%

— Egalet 0.0%

Value ($000) $7 Shares 2,889,926 Est. Cost $5.98 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
REPL	Replimune	5,103,455	$51,035	37.8%	$17.53	-22.9%	Common Stock	76029N106
—	Translate Bio	2,437,603	$18,282	13.6%	$12.65	—	Common Stock	89374L104
—	KezarLife Sciences	675,623	$15,945	11.8%	$17.30	—	Common Stock	49372L100
—	Paratek Pharmaceuticals	2,600,410	$13,340	9.9%	$34.18	—	Common Stock	699374302
—	ObsEva	999,364	$12,652	9.4%	$9.76	—	Common Stock	H5861P103
—	FibroGen	130,646	$6,046	4.5%	$27.34	—	Common Stock	31572Q808
—	CymaBay Therapeutics	551,477	$4,340	3.2%	$4.71	—	Common Stock	23257D103
—	Cidara Therapeutics	1,508,794	$3,546	2.6%	$6.73	—	Common Stock	171757107
—	BSSA Pharma	1,084,848	$2,278	1.7%	$3.00	—	Common Stock	29668H708
—	Pieris Pharmaceuticals	778,230	$2,070	1.5%	$1.83	—	Common Stock	720795103
—	Dicerna Pharmaceuticals	167,157	$1,787	1.3%	$16.47	—	Common Stock	253031108
—	Jounce Therapeutics	529,965	$1,786	1.3%	$21.99	—	Common Stock	481116101
SNNAQ	Sienna Biopharmaceuticals	758,610	$1,760	1.3%	$21.95	-59.8%	Common Stock	82622H108
—	Egalet	2,889,926	$7	0.0%	$5.98	—	Common Stock	28226B104